Antigenicity Preservation Is Related to Tissue Characteristics and the Post-Mortem Interval: Immunohistochemical Study and Literature Review.

autopsy forensic pathology immunohistochemistry post-mortem interval protein degradation time since death

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
08 Aug 2022
Historique:
received: 11 07 2022
revised: 03 08 2022
accepted: 06 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 27 8 2022
Statut: epublish

Résumé

The main aim of this study was to investigate the post-mortem proteolytic degradation process of selected tissue antigens and correlate it to the post-mortem interval. During the autopsy of 12 cadavers (time interval ranging 1 day-2 years after death) samples of skin, liver, kidney, and spleen were collected. All samples were formalin-fixed and paraffin-embedded. Four µm paraffin sections were used for hematoxylin-eosin staining and immunohistochemical analysis (Ki67, Vimentin, Pan cytokeratin, and CD20). Data reported here show that immunohistochemical reactivity preservation was related to the characteristics of the tissues. In particular, the most resistant tissue was the skin, where the autolysis phenomena were not appreciable before 5 days. On the contrary, the liver and the spleen underwent early autolysis, while the kidney displayed an early autolysis of the tubules and a late one of the glomeruli. As concerns specific antigens, immunoreactivity was lost earliest for nuclear antigens as compared to cytoplasmic ones. In conclusion, our results demonstrate that immunohistochemical detection of specific antigens may be useful in estimating the post-mortem interval, especially when we need to know whether the post-mortem interval is a few days or more than 7-10 days.

Identifiants

pubmed: 36011152
pii: healthcare10081495
doi: 10.3390/healthcare10081495
pmc: PMC9408092
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Br J Cancer. 2018 Oct;119(9):1129-1132
pubmed: 30327566
Diagnostics (Basel). 2020 Nov 26;10(12):
pubmed: 33256203
Ann Pathol. 2013 Apr;33(2):93-101
pubmed: 23582835
Urol Oncol. 2019 May;37(5):297.e19-297.e31
pubmed: 30827759
Forensic Sci Med Pathol. 2016 Dec;12(4):451-485
pubmed: 27259559
Cells. 2020 Jun 02;9(6):
pubmed: 32498363
J Forensic Leg Med. 2008 Aug;15(6):368-72
pubmed: 18586206
BMC Cancer. 2014 Apr 23;14:286
pubmed: 24758513
Forensic Sci Int. 2000 Jun 5;110(3):199-206
pubmed: 10842031
Exp Toxicol Pathol. 2004 Dec;56(3):159-71
pubmed: 15625785
Int J Mol Sci. 2019 Jun 23;20(12):
pubmed: 31234562
Forensic Sci Int. 2017 Apr;273:71-79
pubmed: 28236731
Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2104718119
pubmed: 35235452
Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419855226
pubmed: 31179790
Leg Med (Tokyo). 2019 Jul;39:1-8
pubmed: 31078972
J Clin Med. 2020 Jul 13;9(7):
pubmed: 32668651
Forensic Sci Int. 1996 Aug 15;81(2-3):165-74
pubmed: 8837492
J Cell Biol. 2006 Feb 27;172(5):747-58
pubmed: 16505169
Forensic Sci Int. 2001 Nov 1;122(2-3):89-94
pubmed: 11672961
Histopathology. 1990 Dec;17(6):489-503
pubmed: 2076881
Histochem Cell Biol. 2019 Jan;151(1):91-96
pubmed: 30357509
Hum Pathol. 2013 Jul;44(7):1195-215
pubmed: 23427873
J Clin Med. 2019 Oct 11;8(10):
pubmed: 31614564
Forensic Sci Int. 1999 Nov 8;105(3):161-9
pubmed: 10643650
Am J Forensic Med Pathol. 1995 Sep;16(3):203-9
pubmed: 7495259
Int J Legal Med. 2016 Nov;130(6):1547-1555
pubmed: 26951243
Forensic Sci Int. 2007 Jan 17;165(2-3):182-4
pubmed: 16797901
Int J Legal Med. 1994;107(3):132-40
pubmed: 7534470
Microsc Res Tech. 2018 Jul;81(7):745-748
pubmed: 29633435
Forensic Sci Int. 2001 Dec 27;124(2-3):192-9
pubmed: 11792511
Forensic Sci Med Pathol. 2006 Dec;2(4):241-7
pubmed: 25868769
Int J Environ Res Public Health. 2022 Feb 11;19(4):
pubmed: 35206225

Auteurs

Silvestro Mauriello (S)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Michele Treglia (M)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Margherita Pallocci (M)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Rita Bonfiglio (R)

Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Erica Giacobbi (E)

Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Pierluigi Passalacqua (P)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Andrea Cammarano (A)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Cristian D'Ovidio (C)

Department of Medicine and Aging Sciences, University of Chieti-Pescara "G. D'Annunzio", Section of Legal Medicine, 66100 Chieti, Italy.

Luigi Tonino Marsella (LT)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Manuel Scimeca (M)

Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.

Classifications MeSH